Muller-Steffner Hélène, Jacques Sylvain A, Kuhn Isabelle, Schultz Michael D, Botta Davide, Osswald Paul, Maechling Clarisse, Lund Frances E, Kellenberger Esther
Laboratoire des Systèmes Chimiques Fonctionnels, CAMB UMR 7199 CNRS-Université de Strasbourg , MEDALIS Drug Discovery Center, Faculté de Pharmacie, 67400 Illkirch, France.
Laboratoire d'Innovation Thérapeutique, LIT UMR 7200 CNRS-Université de Strasbourg , MEDALIS Drug Discovery Center, Faculté de Pharmacie, 67400 Illkirch, France.
ACS Chem Biol. 2017 Jul 21;12(7):1787-1795. doi: 10.1021/acschembio.7b00186. Epub 2017 May 17.
SmNACE is a NAD catabolizing enzyme expressed on the outer tegument of S. mansoni, a human parasite that is one of the major agents of the neglected tropical disease schistosomiasis. Recently, we identified aroylhydrazone derivatives capable of inhibiting the recombinant form of the enzyme with variable potency (IC ranging from 88 μM to 33 nM). In the present study, we investigated the mechanism of action of the least potent micromolar inhibitor (compound 1) and the most potent nanomolar inhibitor (compound 2) in the series on both the recombinant and native SmNACE enzymes. Using mass spectroscopy, spectrophotometry, and activity assays under different experimental conditions, we demonstrated that the >3 log gain in potency against recombinant SmNACE by this class of compounds is dependent on the formation of a coordination complex with metal cations, such as Ni(II), Zn(II), and Fe(II), that are loaded on the protein surface. Testing the compounds on live parasites, we observed that only the weak micromolar compound 1 was active on the native enzyme. We showed that S. mansoni effectively sequesters the metal from the coordination complex, resulting in the loss of inhibitory activity of the potent nanomolar compound 2. Importantly, the modeling of the transition complex between Zn(II) and compound 2 enabled the discovery of a new metal-independent aroylhydrazone analogue, which is now the most potent and selective inhibitor of native SmNACE known.
SmNACE是一种在曼氏血吸虫外皮层表达的烟酰胺腺嘌呤二核苷酸(NAD)分解代谢酶,曼氏血吸虫是一种人体寄生虫,也是被忽视的热带病血吸虫病的主要病原体之一。最近,我们鉴定出了一系列芳酰腙衍生物,它们能够以不同的效力抑制该酶的重组形式(IC范围为88 μM至33 nM)。在本研究中,我们研究了该系列中效力最低的微摩尔抑制剂(化合物1)和效力最强的纳摩尔抑制剂(化合物2)对重组和天然SmNACE酶的作用机制。在不同实验条件下,通过质谱、分光光度法和活性测定,我们证明了这类化合物对重组SmNACE效力超过3个对数级的提高取决于与负载在蛋白质表面的金属阳离子(如Ni(II)、Zn(II)和Fe(II))形成配位络合物。在活寄生虫上测试这些化合物时,我们观察到只有效力较弱的微摩尔化合物1对天然酶有活性。我们发现曼氏血吸虫能有效地从配位络合物中螯合金属,导致效力强的纳摩尔化合物2失去抑制活性。重要的是,Zn(II)与化合物2之间过渡络合物的建模使得发现了一种新的不依赖金属的芳酰腙类似物,它现在是已知的对天然SmNACE最有效和最具选择性的抑制剂。